Kerry has announced the acquisition of Biosearch Life, a leading biotechnology company focused on providing innovative solutions for the pharmaceutical, nutraceutical and functional food sectors.
Based in Grenada, Spain, Biosearch Life innovates, manufactures and distributes functional ingredients including probiotics, and a portfolio of science-backed botanical extracts and ultra-purified omega-3 oils. The acquisition significantly expands Kerry’s portfolio of science-backed branded ingredients.
Neil Cracknell, president Kerry Applied Health & Nutrition, said, “Our acquisition of Biosearch Life is aligned with our strategic priorities to expand our branded, science backed ingredient portfolio, as well as developing our dietary supplement capabilities and market offering. Biosearch Life extends our probiotics offering with the addition of the science-backed Hereditum strains and further broadens our portfolio with the Exxentia range of functional botanical extracts and Eupoly-3 natural omega-3 oils. These market-leading technologies allow us to address new health need states, enhance our credibility and leadership in science-backed branded actives and supports our ambition to be a leader in sustainable nutrition solutions.”
The Biosearch Life acquisition will be integrated into Kerry’s global ProActive Health platform of science-backed branded ingredients. The growth of this portfolio allows the company to address a wider range of health need states, including healthy aging, joint health and digestive health and reflects the growing number of consumers becoming more proactive in their approach to managing their health. Recent proprietary research completed by Kerry revealed digestive health support was the third most important health benefit consumers globally desired from heathy lifestyle products, an advancement in consumer priority from #4 in 2019 and demonstrates the growing importance of digestive health among consumers—one that probiotics are well suited to deliver on.